--Transaction Includes 23 Approved and 1 Pending Drug Product Applications, Primarily Oral Solutions--
PR Newswire
PHILADELPHIA, May 7, 2018
PR Newswire
PHILADELPHIA, May 7, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey